-
srdrplus.ahrq.gov/published_projects?page=10
November 22, 2023 - or intermediate outcomes) for clinically significant outcomes in patients with OSA, effectively assessing … The SR will attempt to describe heterogeneity of treatment effects in terms of diversity of patient populations … and other providers of care for patients with OSA, healthcare policy makers, and patients. … The SR will attempt to describe heterogeneity of treatment effects in terms of diversity of patient populations … and other providers of care for patients with OSA, healthcare policy makers, and patients.
-
srdrplus.ahrq.gov/published_projects?page=51
June 23, 2021 - in the Pharmacologic Treatment of Adult Depression: An update of the 2007 Comparative Effectiveness … the treatment of depressive disorders, including variations of effects in patients with accompanying … the treatment of acute-phase MDD. … the treatment of dysthymia and subsyndromal depression. … for treatment evaluation in the United States, both in order to summarize the current state of the science
-
srdrplus.ahrq.gov/published_projects?page=40
October 31, 2022 - Recently Published Projects Search for more Projects Published on June 27, 2021 Systematic Review of … Treatments for Basal Cell and Squamous Cell Carcinoma of the Skin 69 Citations • 2 Key Questions • 69 … care for children with indications for tonsillectomy, and for families making treatment decisions. … This report supplies practitioners and researchers up-to-date information about the current state of … evidence and assesses the quality of studies that aim to determine the outcomes and safety of tonsillectomy
-
srdrplus.ahrq.gov/published_projects?page=8
May 30, 2023 - ) treatment of LTBI with pharmacotherapy regimens that are currently recommended by the Centers for Disease … with pulmonary fibrotic lesions; it may overestimate the benefits of treatment for populations with … Contemporary treatment studies have not included placebo arms; benefits and harms of newer treatments … Treatment of LTBI with recommended regimens reduces the risk of progression to active TB. … and patients.
-
srdrplus.ahrq.gov/usage
and is otherwise in compliance with the
license. … For more information, see the Agency for Healthcare
Research and Quality (AHRQ) Privacy Policy ( … the official views of the SRDR team, AHRQ, the
National Institutes of Health (NIH), HHS, or the … The SRDR support team is not required to respond to any comment,
particularly ones that deal with … Thank you for taking the time to review our comment policy.
-
srdrplus.ahrq.gov/published_projects?page=13
September 14, 2022 - READ MORE Published on September 12, 2022 The lack of evidence for PET or PET/CT surveillance of patients … In patients with chronic pain, what is the effectiveness of nonopioid pharmacologic agents versus placebo … In patients with chronic pain, what is the comparative effectiveness of nonopioid pharmacologic agents … In patients with chronic pain, what are the risks of nonopioid pharmacologic agents for harms including … patient comorbidities, (4) dose of medication used, (5) duration of treatment, and (6) dose titration
-
srdrplus.ahrq.gov/published_projects?page=21
June 27, 2021 - Last updated on June 27, 2021 Objectives: 12% of patients with AML harbor mutation at Isocitrate dehydrogenase … Evidence from studies of persons seeking or referred for treatment for substance use or with clinical … treatment, when presenting with signs or symptoms of drug use, when screened for drug use in primary … Naltrexone and methadone/buprenorphine therapy were also associated with increased likelihood of retention … Evidence was lacking on effectiveness of treatments for opioid use disorder related to prescription drug
-
srdrplus.ahrq.gov/published_projects?page=5
October 12, 2023 - Purpose: To systematically review evidence for the effectiveness and harms of screening and treatment … For studies evaluating the benefits and harms of treatment, we included RCTs of lipid-lowering medications … of various lipid-lowering treatments for FH including pharmacotherapy, behavioral counseling, and dietary … of various lipid lowering treatments for multifactorial dyslipidemia. … With the exception of statins evaluated in the FH population, the bodies of evidence for any specific
-
srdrplus.ahrq.gov/published_projects?page=46
June 23, 2021 - , and trials of fluorescent cystoscopy, intravesical therapy, and radiation therapy for NMIBC that evaluated … Intravesical therapy was more effective than no intravesical therapy for reducing risk of bladder cancer … outcomes in patients with T1G3 cancers. … Urinary biomarkers miss a substantial proportion of patients with bladder cancer, and additional research … BCG is the only intravesical therapy shown to be associated with decreased risk of bladder cancer progression
-
srdrplus.ahrq.gov/published_projects?page=22
June 27, 2021 - Recently Published Projects Search for more Projects Published on June 27, 2021 Automated-Entry Patient … Use of Chloroquine and Hydroxychloroquine for Prophylaxis and Treatment of COVID-19 24 Citations • 1 … used alone or when combined with azithromycin for the prophylaxis and treatment of COVID-19. … READ MORE Published on June 27, 2021 Nonopioid Pharmacologic Treatments for Chronic Pain 180 Citations … effectiveness and comparative effectiveness of nonopioid pharmacologic agents in patients with specific
-
srdrplus.ahrq.gov/published_projects?page=38
June 27, 2021 - evidence for the effectiveness of environmental sanitary measures on the prevalence of active trachoma … of patients with onchocerciasis (2016) 3 Citations • 1 Key Questions • 3 Extraction Forms Project created … and treatment of onchocerciasis. … for prevention and treatment of onchocercal ocular lesions in communities co-endemic for onchocerciasis … objective of this review was to assess the effects of corticosteroids on visual recovery in eyes with
-
srdrplus.ahrq.gov/published_projects?page=42
June 27, 2021 - fiber literature for the purposes of conducting a meta-analysis or systematic review. … READ MORE Published on June 27, 2021 The shortcomings of cluster-randomized controlled trials for the … Such disparities may be even more pronounced between certain groups of patients with SMI, differing by … the benefits and harms of second-generation antidepressants (SGAs), psychological treatment options … and as second-step interventions for patients with MDD who did not achieve remission after a first treatment
-
srdrplus.ahrq.gov/published_projects?page=49
June 23, 2021 - the treatment of adults with type 2 diabetes; Data Sources: We searched the MEDLINE, Embase, and Cochrane … choices for patients. … The balance of benefits to harms is favorable for providing prophylaxis to these patients and to extend … READ MORE Published on June 23, 2021 Treatments for Ankyloglossia and Ankyloglossia with Concomitant … We systematically the reviewed the literature on surgical and nonsurgical treatments for infants and
-
srdrplus.ahrq.gov/published_projects?page=23
June 27, 2021 - of therapy for noninvasive nonpharmacological treatment for selected chronic pain conditions. … Evidence on harms was limited, with no evidence suggesting increased risk for serious treatment-related … Chronic low back pain: Psychological therapies were associated with small improvements compared with … course of therapy for specific chronic pain conditions. … beyond the immediate post-treatment period is needed, particularly for conditions other than low back
-
srdrplus.ahrq.gov/published_projects?page=33
June 27, 2021 - Recently Published Projects Search for more Projects Published on June 27, 2021 Treatments for Adults … For drug therapy, the majority of the head to head evidence was on older SGAs, with sparse data on SGAs … Quality of life was improved more with cognitive behavioral therapy and early interventions for FEP than … READ MORE Published on June 27, 2021 Systematic Review on the Use of Cryotherapy Versus other Treatments … events profile of cryotherapy for the treatment of basal cell carcinoma compared to other therapeutic
-
srdrplus.ahrq.gov/published_projects?page=45
June 23, 2021 - This review examines the evidence on the comparative benefits and harms of noninvasive treatments for … Most trials enrolled patients with pain symptoms of at least moderate intensity (e.g., >5 on a 0- to … For chronic low back pain, effective therapies versus placebo, sham, no treatment, usual care, or wait … Few trials evaluated the effectiveness of treatments for radicular low back pain, but the available evidence … of treatments, effectiveness of treatments for radicular low back pain, and effectiveness on outcomes
-
srdrplus.ahrq.gov/published_projects?page=11
October 25, 2022 - versus placebo or no treatment, recently approved medical therapies versus older therapies, and selective … Evidence on the accuracy of instruments for identifying patients at higher risk of glaucoma was limited … versus placebo or no treatment, recently approved medical therapies versus older therapies, and selective … Evidence on the accuracy of instruments for identifying patients at higher risk of glaucoma was limited … to patients with marked dyslipidemia.
-
srdrplus.ahrq.gov/published_projects?page=19
June 27, 2021 - therapy in patients with specific types of acute pain, including effects on pain, function, quality … for the acute treatment of episodic migraine in adults. … Compared with placebo, several non-pharmacologic treatments may improve various measures of pain, including … A number of acute treatments for episodic migraine exist with varying degrees of evidence for effectiveness … The evidence base for many other interventions for acute treatment, including opioids, remains limited
-
srdrplus.ahrq.gov/published_projects?page=7
June 13, 2023 - comparative effectiveness and harms of external beam radiation therapy (EBRT) for palliative treatment … with pulmonary fibrotic lesions; it may overestimate the benefits of treatment for populations with … Contemporary treatment studies have not included placebo arms; benefits and harms of newer treatments … with pulmonary fibrotic lesions; it may overestimate the benefits of treatment for populations with … Contemporary treatment studies have not included placebo arms; benefits and harms of newer treatments
-
srdrplus.ahrq.gov/blog
August 26, 2021 - At
the time, I was not particularly mindful of the andragogical utility
of any … of the tools I... … after the
review is complete, and sharing the data with others (including
other … systematic reviewers, clinical guideline developers,
healthcare professionals, patients … sharing the results of
systematic reviews.